Zymeworks (ZYME) Current Assets (2021 - 2026)

Zymeworks has disclosed Current Assets across 6 years of filings, most recently posting $385.7 million for Q1 2026.

• Current Assets for Q1 2026 came in at $385.7 million, up 25.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $385.7 million (up 25.85% YoY), and the FY2025 annual result was $248.8 million, down 17.2% from the prior year.
• Current Assets came in at $385.7 million for Q1 2026 at Zymeworks, up from $248.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $544.7 million in Q4 2022 to a low of $190.7 million in Q3 2022.
• The 5-year median for Current Assets is $374.6 million (2023), against an average of $354.7 million.
• Across the five-year window, Current Assets soared 96.5% in 2023 and declined 27.24% in 2024, its largest moves.
• Zymeworks' Current Assets stood at $544.7 million in 2022, then dropped by 24.19% to $412.9 million in 2023, then retreated by 27.24% to $300.5 million in 2024, then retreated by 17.2% to $248.8 million in 2025, then soared by 55.04% to $385.7 million in 2026.
• The last three Current Assets figures came in at $385.7 million (Q1 2026), $248.8 million (Q4 2025), and $291.7 million (Q3 2025), per Business Quant data.